Xenoport Sees Positive Study Data - Forbes.com

Xenoport Sees Positive Study Data - Forbes.com: "Biopharmaceutical company Xenoport Inc. said Wednesday its primary restless legs syndrome treatment candidate showed positive results in a late-stage clinical trial."